NEA Management Company, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 98 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.0%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$15,760,000
-26.1%
25,243,8650.0%0.74%
-57.8%
Q3 2019$21,318,000
+26.0%
25,243,8650.0%1.76%
+48.9%
Q2 2019$16,913,000
-1.3%
25,243,865
+20.8%
1.18%
+33.1%
Q1 2019$17,135,000
-48.7%
20,896,0380.0%0.89%
-32.9%
Q4 2018$33,434,000
-46.0%
20,896,038
+11.8%
1.33%
-50.4%
Q3 2018$61,891,000
+54.4%
18,698,038
+5.1%
2.67%
+42.2%
Q2 2018$40,091,000
-15.5%
17,783,722
+8.7%
1.88%
-11.0%
Q1 2018$47,452,000
+3.9%
16,362,6940.0%2.11%
+11.6%
Q4 2017$45,652,000
-23.6%
16,362,6940.0%1.89%
-9.6%
Q3 2017$59,724,000
+64.4%
16,362,6940.0%2.09%
+58.2%
Q2 2017$36,325,000
+276.3%
16,362,6940.0%1.32%
+293.5%
Q1 2017$9,654,000
+72.5%
16,362,694
+57.9%
0.34%
+50.7%
Q4 2016$5,596,000
-39.3%
10,362,6940.0%0.22%
-46.1%
Q3 2016$9,223,000
-7.3%
10,362,6940.0%0.41%
-19.8%
Q2 2016$9,948,00010,362,6940.52%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders